MeMed

MeMed is an Israeli Med-Tech company that develops novel patient management solutions by decoding signals of the host-immune system and translating them into actionable insights that transform the way infectious diseases and inflammatory disorders are diagnosed and treated. To that end, MeMed draws on multidisciplinary expertise in the fields of immunology, biochemistry, engineering, and machine learning. MeMed’s products are sold to hospitals in the US, Europe, and Israel.